- Home
- Media Center
- Press releases
- Financial
Financial
Johnson & Johnson Reports 2011 Third-Quarter Results
Sales of $16.0 Billion increased 6.8% Versus 2010 Third-Quarter; Third Quarter EPS was $1.15Excluding Special Items, 2011 Third-Quarter EPS of $1.24, increased 0.8%*
Janssen Data Focus On Tolerability and Treatment Simplification in HIV Compounds
New HIV data to be presented at EACS 2011
Stigma Remains a Significant Barrier to Routine HIV Testing by African-American Physicians, Survey Finds
Physicians Report Only One-Third of Patients Routinely Tested in the Past Year Despite Growing Prevalence of HIV Diagnoses Among African Americans
Johnson & Johnson Reports 2011 Second-Quarter Results:
Sales of $16.6 Billion Increased 8.3% Versus 2010 Second-Quarter; Second-Quarter EPS was $1.00Excluding Special Items, 2011 Second-Quarter EPS of $1.28 Increased 5.8%*